Navigation Links
Immucor and Alverno Clinical Laboratories Sign Five-Year Automation Agreement

NORCROSS, Ga., May 27 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today that it has signed a five-year agreement with Alverno Clinical Laboratories, LLC, one of the largest regional hospital laboratory integrated delivery systems in the nation, serving 27 hospitals in Illinois and Indiana.

Under the agreement, Alverno is standardizing pre-transfusion testing in 26 facilities with Immucor automation through the acquisition of 24 Echo instruments and 2 Capture Workstations. Additionally, Immucor will be the primary source for Alverno's blood bank reagent needs.

"We are pleased to partner with such an innovative organization as Alverno," stated Dr. Gioacchino De Chirico, President and Chief Executive Officer of Immucor. "We believe that integrated delivery networks can achieve significant benefits both in terms of improving operational efficiency and improving patient safety through standardizing their blood bank operations with Immucor automation."

"Our goal is to produce accurate and timely test results while implementing standardized best practices across all laboratory sites," stated Sam Terese, Chief Operating Officer of Alverno Clinical Laboratories. "We chose Immucor due to the exceptional functionality of the Echo instrument and its fit with LEAN operations as well as Immucor's commitment to improving transfusion medicine."

Immucor's innovative automation strategy provides scalable solutions to meet the needs of all blood banks, regardless of size. Immucor has continually invested in automation since 1998, most recently with the Echo instrument. The Echo, which is designed for smaller volume laboratories, features a broad test menu, instant access and the industry's fastest turnaround times.

About Alverno Clinical Laboratories

Located in Hammond, In., Alverno Clinical Laboratories, LLC is one of the largest regional hospital laboratory integrated delivery systems in the nation. Alverno's operations include a regional core laboratory, 27 hospital laboratories, and a network of patient service centers in both Indiana and Illinois. Alverno is a joint venture of the Sisters of St. Francis Health Services, Inc., Resurrection Health Care and Provena Health. For more information on Alverno, please visit our website at

About Immucor

Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of its market segments. For more information on Immucor, please visit our website at

SOURCE Immucor, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Immucor Schedules Second Quarter Earnings Release and Conference Call
2. FDA Accepts Immucors Response to Warning Letter
3. Immucor Announces Fiscal Year 2009 Revenue and Earnings Guidance
4. Immucor CEOs Italian Trial Moves Toward Second Phase
5. Immucor To Acquire BioArray Solutions Ltd.
6. Immucor Responding to FTC Inquiry
7. Immucor Settles SEC Investigation
8. Clinical Data on Peregrines Bavituximab Cancer Program to Be Discussed in Two Presentations at 2009 ASCO Annual Meeting
9. Senesco Presents Pre-Clinical Multiple Myeloma Data at the 12th Annual Meeting of the American Society of Gene Therapy
10. Lexicon to Present Clinical Data for LX1031 and LX1032 at Digestive Disease Week
11. Medarex to Host Clinical Program Update Conference Call on Tuesday, June 2, 2009
Post Your Comments:
(Date:11/30/2015)... ... 2015 , ... Global Stem Cells Group today ... Santiago Marriott. The Global Stem Cells Group GMP facility is equipped with the ... medical researchers and practitioners, experienced in administering stem cell protocols using highly manipulated ...
(Date:11/30/2015)... Partnership includes an MPP licen ... niversity , s Solid Drug Nanoparticle (SDN) Technology ... up through cost cuts of priority ... licensees based anywhere in the world will have the right to make, use and ... , where licensees based anywhere in the world will have the right to make, ...
(Date:11/30/2015)... BETHESDA, Md. , Nov. 30, 2015 /PRNewswire/ ... property development company committed to the fostering and ... on the current and prospective initiatives designed to ... , Chief Executive Officer of Spherix. "Based on ... potential future licensees exceeds $50 billion and Spherix ...
(Date:11/30/2015)... Florida , November 30, 2015 ... specializing in the development of innovative peptide and gene-based ... metastatic disease, today announced it will be presenting at ... on December 1, 2015 at 2.30 PM PT. Dr. ... and Strategic Advisor will be giving the presentation and ...
Breaking Biology Technology:
(Date:11/26/2015)... 26, 2015 Research and Markets ( ... Fingerprint Sensors - Technology and Patent Infringement Risk Analysis" ... --> --> Fingerprint sensors using capacitive ... The fingerprint sensor vendor Idex forecasts an increase of ... mobile devices and of the fingerprint sensor market between ...
(Date:11/18/2015)... New York , November 18, 2015 ... Market Research has published a new market report titled ... Growth, Trends, and Forecast, 2015 - 2021. According to the ... in 2014 and is anticipated to reach US$29.1 bn ... to 2021. North America ...
(Date:11/16/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced expansion of its TDDI product portfolio with ... and display driver integration (TDDI) solutions designed to ... TDDI products add to the previously-announced TD4300 ... resolution), and TD4322 (FHD resolution) solutions. All four ...
Breaking Biology News(10 mins):